首页> 外文期刊>Food & Function >Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-gamma and SREBP-1c in diet-induced obese mice
【24h】

Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-gamma and SREBP-1c in diet-induced obese mice

机译:芙蓉水提取物通过下调饮食诱导的肥胖小鼠中的PPAR-γ和SREBP-1c减轻肝脂肪变性

获取原文
获取原文并翻译 | 示例
           

摘要

The growing incidence of obesity is a worldwide public health problem leading to a risk factor for non-alcoholic fatty liver disease, which extends from steatosis to steatohepatitis and cirrhosis. We investigated whether the aqueous extract of Hibiscus sabdariffa L. (Hs) reduces body weight gain and protects the liver by improving lipid metabolism in high fat diet-induced obese C57BL/6NHsd mice. We found that oral administration of the Hs extract reduced fat tissue accumulation, diminished body weight gain and normalized the glycemic index as well as reduced dyslipidemia compared to the obese mice group that did not receive Hs treatment. In addition, Hs treatment attenuated liver steatosis, down-regulated SREBP-1c and PPAR-gamma, blocked the increase of IL-1, TNF-alpha mRNA and lipoperoxidation and increased catalase mRNA. Our results suggest that the anti-obesity, anti-lipidemic and hepatoprotective effects of the Hs extract are related to the regulation of PPAR-gamma and SREBP-1c in the liver.
机译:肥胖症发病率的上升是一个全球性的公共卫生问题,是导致非酒精性脂肪肝疾病的危险因素,非酒精性脂肪肝疾病从脂肪变性延伸到脂肪性肝炎和肝硬化。我们调查了芙蓉(Hs)的水提取物是否通过改善高脂饮食诱导的肥胖C57BL / 6NHsd小鼠的脂质代谢来减轻体重增加并保护肝脏。我们发现,与未接受Hs治疗的肥胖小鼠组相比,口服Hs提取物可减少脂肪组织积累,减少体重增加,使血糖指数正常化以及血脂异常。此外,Hs治疗可减轻肝脏脂肪变性,下调SREBP-1c和PPAR-γ,阻止IL-1,TNF-αmRNA和脂过氧化的增加以及过氧化氢酶mRNA的增加。我们的结果表明,Hs提取物的抗肥胖,抗血脂和保肝作用与肝脏中PPAR-γ和SREBP-1c的调节有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号